scholarly article | Q13442814 |
P2093 | author name string | Fan Yang | |
Dong Lu | |||
Bin Lan | |||
Zhenlv Lin | |||
P2860 | cites work | VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 |
A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema | Q68167037 | ||
Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies | Q33763285 | ||
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial | Q33872486 | ||
IBD-what role do Proteobacteria play? | Q34255700 | ||
Fecal microbiota transplantation: past, present and future | Q34304193 | ||
A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy | Q34442836 | ||
Evaluation of dairy allergy among ulcerative colitis patients. | Q34454060 | ||
Food antigen-induced immune responses in Crohn's disease patients and experimental colitis mice | Q35288822 | ||
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. | Q35760489 | ||
Immunopathogenesis of IBD: current state of the art. | Q35857951 | ||
IL-10-Producing Regulatory B Cells Are Decreased in Patients with Common Variable Immunodeficiency | Q35962914 | ||
Specific immunotherapy in combination with Clostridium butyricum inhibits allergic inflammation in the mouse intestine | Q36340310 | ||
IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses | Q36500626 | ||
Mesenteric IL-10-producing CD5+ regulatory B cells suppress cow's milk casein-induced allergic responses in mice | Q36500780 | ||
Medical treatment of ulcerative colitis | Q37427481 | ||
Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'? | Q38234705 | ||
International consensus on allergy immunotherapy. | Q38544969 | ||
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis. | Q38631553 | ||
Probiotics: Potent Immunomodulatory Tool Against Allergy | Q38701813 | ||
TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation | Q39010812 | ||
Food allergy among Iranian children with inflammatory bowel disease: A preliminary report | Q40115411 | ||
TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. | Q40412394 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunotherapy | Q1427096 |
Clostridium butyricum | Q2622044 | ||
P304 | page(s) | 25587 | |
P577 | publication date | 2016-05-11 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Specific immunotherapy plus Clostridium butyricum alleviates ulcerative colitis in patients with food allergy | |
P478 | volume | 6 |
Search more.